Net Cash Provided by (Used in) Operating Activities of CytoDyn Inc. from 31 Aug 2010 to 31 Aug 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
CytoDyn Inc. quarterly and annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Aug 2010 to 31 Aug 2025.
  • CytoDyn Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Aug 2025 was $2,450,000, a 145% decline year-over-year.
  • CytoDyn Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $8,765,000, a 20% increase from 2023.
  • CytoDyn Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $10,982,000, a 56% increase from 2022.
  • CytoDyn Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was $25,110,000, a 68% increase from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

CytoDyn Inc. Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,450,000 -$7,890,000 -145% 01 Jun 2025 31 Aug 2025 10-Q 10 Oct 2025 2026 Q1
Q3 2024 $5,440,000 +$9,935,000 01 Jun 2024 31 Aug 2024 10-Q 10 Oct 2025 2026 Q1
Q3 2023 $4,495,000 +$6,579,000 +59% 01 Jun 2023 31 Aug 2023 10-Q 15 Oct 2024 2025 Q1
Q3 2022 $11,074,000 +$20,667,000 +65% 01 Jun 2022 31 Aug 2022 10-Q 23 Oct 2023 2024 Q1
Q3 2021 $31,741,000 +$9,207,000 +22% 01 Jun 2021 31 Aug 2021 10-Q/A 13 Oct 2022 2023 Q1
Q3 2020 $40,948,000 -$25,758,000 -170% 01 Jun 2020 31 Aug 2020 10-Q 12 Oct 2021 2021 Q1
Q3 2019 $15,190,000 -$6,219,340 -69% 01 Jun 2019 31 Aug 2019 10-Q 09 Oct 2020 2020 Q1
Q3 2018 $8,970,660 -$1,970,551 -28% 01 Jun 2018 31 Aug 2018 10-Q 08 Oct 2019 2020 Q1
Q3 2017 $7,000,109 01 Jun 2017 31 Aug 2017 10-Q 09 Oct 2018 2019 Q1
Q3 2013 $804,725 -$393,695 -96% 01 Jun 2013 31 Aug 2013 10-Q 15 Oct 2013 2014 Q1
Q3 2012 $411,030 +$134,219 +25% 01 Jun 2012 31 Aug 2012 10-Q 15 Oct 2013 2014 Q1
Q3 2011 $545,249 -$239,880 -79% 01 Jun 2011 31 Aug 2011 10-Q/A 08 Nov 2012 2013 Q1
Q3 2010 $305,369 01 Jun 2010 31 Aug 2010 10-Q/A 30 Nov 2011 2012 Q1

CytoDyn Inc. Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $8,765,000 +$2,217,000 +20% 01 Jun 2024 31 May 2025 10-K 25 Jul 2025 2025 FY
2023 $10,982,000 +$14,128,000 +56% 01 Jun 2023 31 May 2024 10-K 25 Jul 2025 2025 FY
2022 $25,110,000 +$52,613,000 +68% 01 Jun 2022 31 May 2023 10-K 15 Aug 2024 2024 FY
2021 $77,723,000 +$39,850,000 +34% 01 Jun 2021 31 May 2022 10-K 14 Sep 2023 2023 FY
2020 $117,573,000 -$48,769,000 -71% 01 Jun 2020 31 May 2021 10-K 15 Aug 2022 2022 FY
2019 $68,804,000 -$18,338,000 -36% 01 Jun 2019 31 May 2020 10-K 15 Aug 2022 2022 FY
2018 $50,466,000 -$20,568,029 -69% 01 Jun 2018 31 May 2019 10-K 30 Jul 2021 2021 FY
2017 $29,897,971 -$3,165,503 -12% 01 Jun 2017 31 May 2018 10-K 14 Aug 2020 2020 FY
2016 $26,732,468 -$1,921,817 -7.7% 01 Jun 2016 31 May 2017 10-K 14 Aug 2019 2019 FY
2015 $24,810,651 01 Jun 2015 31 May 2016 10-K 27 Jul 2018 2018 FY
2013 $7,386,943 -$3,994,010 -118% 01 Jun 2013 31 May 2014 10-K 10 Jul 2014 2014 FY
2012 $3,392,933 +$998,162 +23% 01 Jun 2012 31 May 2013 10-K 10 Jul 2014 2014 FY
2011 $4,391,095 -$2,569,678 -141% 01 Jun 2011 31 May 2012 10-K 29 Aug 2013 2013 FY
2010 $1,821,417 01 Jun 2010 31 May 2011 10-K 22 Aug 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.